Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors. Now, researchers at University of California San Diego School of Medicine ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...

Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...

Researchers at KAIST in South Korea have discovered a new way to treat cancer. They can reprogram cancer cells to become normal cells. The technique u ...

Researchers at the University of Cincinnati Cancer Center have made significant strides in understanding how lymphoma, a type of blood cancer, is driven by the dysregulation of a key oncogene ...

A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in the development and progression of cancer, spotlighting its potential as a multidimensional ...

The researchers found that when MYC initially becomes upregulated in precancerous cells, activity increases in pathways that alert the immune system that something is wrong.